BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 26621208)

  • 1. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
    Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
    World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
    Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
    Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies.
    Bi L; Huang H; Fan X; Li K; Xu K; Jiang C; Liu H; Dong W; Zhang S; Yang X; Lin T; Huang J
    BJU Int; 2014 May; 113(5b):E39-48. PubMed ID: 24053715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer.
    von Deimling M; Furrer M; Mertens LS; Mari A; van Ginkel N; Bacchiani M; Maas M; Pichler R; Li R; Moschini M; Bianchi A; Vetterlein MW; Lonati C; Crocetto F; Taylor J; Tully KH; Afferi L; Soria F; Del Giudice F; Longoni M; Laukhtina E; Antonelli A; Rink M; Fisch M; Lotan Y; Spiess PE; Black PC; Kiss B; Pradere B; Shariat SF;
    BJU Int; 2024 Mar; 133(3):341-350. PubMed ID: 37904652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
    Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
    Jensen JB; Ulhøi BP; Jensen KM
    Int J Urol; 2012 Jan; 19(1):39-47. PubMed ID: 22050425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
    Zehnder P; Studer UE; Skinner EC; Dorin RP; Cai J; Roth B; Miranda G; Birkhäuser F; Stein J; Burkhard FC; Daneshmand S; Thalmann GN; Gill IS; Skinner DG
    J Urol; 2011 Oct; 186(4):1261-8. PubMed ID: 21849183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma.
    Crozier J; Papa N; Perera M; Stewart M; Goad J; Sengupta S; Bolton D; Lawrentschuk N
    Investig Clin Urol; 2017 Nov; 58(6):416-422. PubMed ID: 29124240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study.
    Siemens DR; Mackillop WJ; Peng Y; Wei X; Berman D; Booth CM
    Urol Oncol; 2015 Oct; 33(10):425.e15-23. PubMed ID: 26199175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
    Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoendoscopic Single-Site Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Patient with Bladder Urothelial Carcinoma: Matched Case-Control Analysis.
    Xu K; Lang B; Fu B; Shi T; Wang B; Zhang X
    J Endourol; 2017 Dec; 31(12):1259-1268. PubMed ID: 28967303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
    Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
    Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer.
    Perera M; McGrath S; Sengupta S; Crozier J; Bolton D; Lawrentschuk N
    Nat Rev Urol; 2018 Nov; 15(11):686-692. PubMed ID: 30104615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic extended pelvic lymphadenectomy for bladder cancer with increased nodal yield.
    Lavery HJ; Martinez-Suarez HJ; Abaza R
    BJU Int; 2011 Jun; 107(11):1802-5. PubMed ID: 21070571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer.
    Fang AC; Ahmad AE; Whitson JM; Ferrell LD; Carroll PR; Konety BR
    Cancer; 2010 Apr; 116(8):1901-8. PubMed ID: 20186823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.